These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8118603
21. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Peng H, Chen G, Du M, Singh N, Isaacson PG, Pan L. Am J Pathol; 1996 Feb; 148(2):643-8. PubMed ID: 8579126 [Abstract] [Full Text] [Related]
22. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L, Grandi E, Boiocchi M. Oncogene; 1992 Jun; 7(6):1159-66. PubMed ID: 1594246 [Abstract] [Full Text] [Related]
23. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. Dong M, Nio Y, Yamasawa K, Toga T, Yue L, Harada T. J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067 [Abstract] [Full Text] [Related]
24. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance. Laframboise S, Chapman W, McLaughlin J, Andrulis IL. Cancer J; 2000 Feb; 6(5):302-8. PubMed ID: 11079169 [Abstract] [Full Text] [Related]
25. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China. Lung ML, Chan WC, Zong YS, Tang CM, Fok CL, Wong KT, Chan LK, Lau KW. Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219 [Abstract] [Full Text] [Related]
26. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE. Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328 [Abstract] [Full Text] [Related]
27. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer? Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Amato A, Calò V, Dardanoni G, Morello V, La Farina M, Albanese I, Tomasino RM, Gebbia N, Russo A. J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467 [Abstract] [Full Text] [Related]
28. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment. Chawengchao B, Petmitr S, Ponglikitmongkol M, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W. Anticancer Res; 2001 May; 21(4A):2739-43. PubMed ID: 11724349 [Abstract] [Full Text] [Related]
29. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY, Lin SR, Hsieh JS, Hsu CH, Huang YS, Huang TJ. Anticancer Res; 2001 May; 21(1B):513-20. PubMed ID: 11299797 [Abstract] [Full Text] [Related]
30. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Kropveld A, Rozemuller EH, Leppers FG, Scheidel KC, de Weger RA, Koole R, Hordijk GJ, Slootweg PJ, Tilanus MG. Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071 [Abstract] [Full Text] [Related]
31. Analysis of p53 abnormalities in endoscopic gastric biopsies. Imatani A, Sasano H, Asaki S, Toyota T, Saito M, Masuda T, Nagura H. Anticancer Res; 1996 Mar; 16(4A):2049-56. PubMed ID: 8712741 [Abstract] [Full Text] [Related]
32. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer. Nayak BK, Baral RN, Das BR. Neoplasma; 1996 Mar; 43(5):305-10. PubMed ID: 8996549 [Abstract] [Full Text] [Related]
33. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing. Hunter SB, Bandea C, Swan D, Abbott K, Varma VA. Mod Pathol; 1993 Jul; 6(4):442-5. PubMed ID: 8415589 [Abstract] [Full Text] [Related]
34. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS. Cancer Res; 1993 Jul 15; 53(14):3374-81. PubMed ID: 8324748 [Abstract] [Full Text] [Related]
35. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Gynecol Oncol; 1997 Apr 15; 65(1):23-9. PubMed ID: 9103386 [Abstract] [Full Text] [Related]
36. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M. Clin Cancer Res; 2001 Dec 15; 7(12):3977-87. PubMed ID: 11751490 [Abstract] [Full Text] [Related]
37. p53 mutations and histological type of invasive breast carcinoma. Marchetti A, Buttitta F, Pellegrini S, Campani D, Diella F, Cecchetti D, Callahan R, Bistocchi M. Cancer Res; 1993 Oct 01; 53(19):4665-9. PubMed ID: 8402644 [Abstract] [Full Text] [Related]
38. p53 alterations in uterine leiomyosarcomas versus leiomyomas. de Vos S, Wilczynski SP, Fleischhacker M, Koeffler P. Gynecol Oncol; 1994 Aug 01; 54(2):205-8. PubMed ID: 8063247 [Abstract] [Full Text] [Related]
39. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma. Matsuura S, Oda Y, Matono H, Izumi T, Yamamoto H, Tamiya S, Iwamoto Y, Tsuneyoshi M. Hum Pathol; 2010 Mar 01; 41(3):343-51. PubMed ID: 19896699 [Abstract] [Full Text] [Related]
40. p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma. Hughes JH, Cohen MB, Robinson RA. Mod Pathol; 1995 Jun 01; 8(5):462-6. PubMed ID: 7675761 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]